Verrica Pharmaceuticals Inc.
Clinical trials sponsored by Verrica Pharmaceuticals Inc., explained in plain language.
-
New gel could zap away common warts in just weeks
Disease control Recruiting nowThis study tests a medicated gel called YCANTH on common warts caused by HPV. About 300 people aged 2 and older with at least one wart will apply the gel or a fake version. The goal is to see if the gel safely clears all warts by day 84.
Phase: PHASE3 • Sponsor: Verrica Pharmaceuticals Inc. • Aim: Disease control
Last updated May 26, 2026 08:51 UTC
-
New gel shows promise for stubborn warts in extended trial
Disease control Recruiting nowThis study follows people who previously took part in a wart treatment study (COVE-2 or COVE-3) to see if YCANTH gel is safe and works over a longer period. Participants with remaining warts can get up to 4 more treatments, applied every 21 days. The goal is to clear all warts, a…
Phase: PHASE3 • Sponsor: Verrica Pharmaceuticals Inc. • Aim: Disease control
Last updated May 19, 2026 11:48 UTC